Beta-O2 Technologies Ltd. | Press Releases

Press Releases

Encapsulation: An Overview of Competitors.

January 22, 2019

Global Bio-Artificial Pancreas Market 2019 – Medtronic, Beta-O2 Technologies Ltd, JDRF, Defymed, TypeZero Technologies

May 10, 2019

Device could help insulin-producing cells live longer after transplant and improve treatment of type 1 diabetes

April 25, 2018

Practical Cure Project Update: Beta-02 ßAir Bio-Artificial Pancreas

February 23, 2017

Beta-O2 Names Dr. Yuval Avni CEO.
Sherpa Innoventures joins list of company investors

March, 30, 2015

Beta-O2’s ßAir Bio-artificial Adrenal Device Shows Potential to Treat Adrenocortical Insufficiency and Other Stress-related Disorders

Feb, 19, 2015

First Patient Successfully Implanted in Safety/Efficacy Study of Beta-O2’s ßAir Bio-Artificial Pancreas for Type 1 Diabetes

Oct, 21, 2014

Beta O2 has received a grant from JDRF to conduct a clinical trial of the βAir Bio-Artificial Pancreas as a Potential Cure for Type 1 Diabetes

Sept, 10, 2014